Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreMonica Bertagnolli, MD, the new director of the National Institutes of Health (NIH), and Robert Califf, MD, commissioner of the U.S. Food and Drug Administration, this week focused on clinical trials and efficiencies, and data management during presentations at the Friends of Cancer Research annual meeting in Washington, DC.
Dr. Bertagnolli emphasized the importance of designing evidence to bring the doctor and patient together in decision-making events and seeing the clinical care environment as a learning laboratory. She also highlighted the federal government’s need to increase enrollment in clinical trials to expand opportunities for patient access and diversity. The topic of clinical trials is of interest to the American College of Radiology® (ACR®), as ACR has been fortunate to partner with NIH, specifically in the National Cancer Institute’s clinical trials network.
A recording of the meeting is available online.
For more information, contact Katie Grady, ACR Government Affairs Director.
Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreRAPID Pathway for Device Coverage
RAPID pathway could streamline Medicare coverage decisions for eligible breakthrough devices through earlier review alignment.
Read moreDetailed Summary of FY2027 IPPS Final Rule
CMS finalized FY 2027 hospital payment updates, including a 2.3% increase, new technology payments and AI-related policy changes.
Read more